HIGHLIGHTS
- who: Natalya Khodeneva et al. from the University of Padua, Italy have published the research work: Melanocortin therapies to resolve fibroblast-mediated diseases, in the Journal: (JOURNAL)
- what: The approaches discussed above are aimed the prevention or de-activation of fibroblast aggressive phenotypes. The authors focus on exploring and revising the existing evidence for the use of melanocortin based therapies for the management of fibroblasts mediated conditions. Much of the work described above has been generated by Bu00f6hm and colleagues, who also provided useful insights into the actions of these drugs using in_vivo models of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.